Serious adverse events · people with systemic sclerosis
Autologous non‐myeloablative selective HSCT probably leads to higher serious adverse events compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Overall mortality · people with systemic sclerosis
1 finding from 1 review
Event‐free survival · people with systemic sclerosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functional ability · people with systemic sclerosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Skin thickness – mRSS Scale 0–51 in which a higher number is worse skin thickening · people with systemic sclerosis
1 finding from 1 review
Interstitial lung disease – FVC % predicted A lower percentage represents worse lung disease. The study incorporated a ≥ 15% chance · people with systemic sclerosis
1 finding from 1 review
Pulmonary arterial hypertension · people with systemic sclerosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with systemic sclerosis
1 finding from 1 review
Intervention not reported
Number of patients with at least 30% pain reduction · Patients with fibromyalgia
It is very uncertain whether the intervention changes number of patients with at least 30% pain reduction (very low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with a clinically important global improvement · Patients with fibromyalgia
It is very uncertain whether the intervention changes number of patients with a clinically important global improvement (very low certainty).
1 finding from 1 review
Intervention not reported
Fatigue (lower scores mean less fatigue) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Sleep problems (lower scores mean less sleep problems) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Depression (lower scores mean less depression) · Patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Discontinuation due to adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes discontinuation due to adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · Patients with fibromyalgia
It is very uncertain whether the intervention changes serious adverse events (very low certainty).
1 finding from 1 review